Scientists from Sanford Burnham Prebys have created natural-looking hair that grows through the skin using human induced pluripotent stem cells (iPSCs), a major scientific achievement that could revolutionize the hair growth industry.
The findings were presented today at the annual meeting of the International Society for Stem Cell Research (ISSCR) and received a Merit Award. A newly formed company, Stemson Therapeutics, has licensed the technology.
More than 80 million men, women and children in the United States experience hair loss. Genetics, aging, childbirth, cancer treatment, burn injuries and medical disorders such as alopecia can cause the condition. Hair loss is often associated with emotional distress that can reduce quality of life and lead to anxiety and depression.
“Our new protocol described today overcomes key technological challenges that kept our discovery from real-world use,” says Alexey Terskikh, Ph.D., an associate professor in Sanford Burnham Prebys’ Development, Aging and Regeneration Program and the co-founder and chief scientific officer of Stemson Therapeutics. “Now we have a robust, highly controlled method for generating natural-looking hair that grows through the skin using an unlimited source of human iPSC-derived dermal papilla cells. This is a critical breakthrough in the development of cell-based hair-loss therapies and the regenerative medicine field.”
Terskikh studies a type of cell called dermal papilla. Residing inside the hair follicle, these cells control hair growth, including hair thickness, length and growth cycle. In 2015, Terskikh successfully grew hair underneath mouse skin (subcutaneous) by creating dermal papilla derived from human pluripotent stem cells—a tantalizing but uncontrolled process that required further refinement.
The approach detailed in the ISSCR presentation, which was delivered by lead researcher Antonella Pinto, Ph.D., a postdoctoral researcher in the Terskikh lab, features a 3D biodegradable scaffold made from the same material as dissolvable stitches. The scaffold controls the direction of hair growth and helps the stem cells integrate into the skin, a naturally tough barrier. The current protocol relies on mouse epithelial cells combined with human dermal papilla cells. The experiments were conducted in immunodeficient nude mice, which lack body hair.
The derivation of the epithelial part of a hair follicle from human iPSCs is currently underway in the Terskikh lab. Combined human iPSC-derived epithelial and dermal papilla cells will enable the generation of entirely human hair follicles, ready for allogenic transplantation in humans. Distinct from any other approaches to hair follicle regeneration, human iPSCs provide an unlimited supply of cells and can be derived from a simple blood draw.
“Hair loss profoundly affects many people’s lives. A significant part of my practice involves both men and women who are seeking solutions to their hair loss,” says Richard Chaffoo, M.D., F.A.C.S., a triple board-certified plastic surgeon who founded La Jolla Hair MD and is a medical adviser to Stemson Therapeutics. “I am eager to advance this groundbreaking technology, which could improve the lives of millions of people who struggle with hair loss.”
The technology was discovered and developed at Sanford Burnham Prebys. Further development and commercialization activities will be conducted by Stemson Therapeutics. For updates on the technology’s progress and advancement, please visit www.stemsontx.com.
Learn more: Functional hair follicles grown from stem cells
The Latest on: Induced pluripotent stem cells
via Google News
The Latest on: Induced pluripotent stem cells
- First supercentenarian-derived stem cells createdon March 20, 2020 at 7:32 am
However, we don't know why some people become supercentenarians and others do not. Now, for the first time, scientists have reprogrammed cells from a 114-year-old woman into induced pluripotent stem ...
- Transcriptomic Landscape and Functional Characterization of Induced Pluripotent Stem Cell-Derived Cerebral Organoids in Schizophrenia.on March 19, 2020 at 8:07 am
Three-dimensional cerebral organoids generated from patient-derived induced pluripotent stem cells (iPSCs) may be used to interrogate cellular-molecular underpinnings of schizophrenia. To determine ...
- Induced Pluripotent Stem Cells Market Recent Study including Growth Factors, Applications, Regional Analysis, Key Players and Forecast till 2027on March 19, 2020 at 4:13 am
Induced Pluripotent Stem Cells Market business research report assesses the current as well as upcoming performance of the market and also brand new trends in the market It provides product overview ...
- Induced Pluripotent Stem Cells Market | Size, Growth Rate, Trends, Key Company Share, Regional Analysis, And Global Industry Forecast 2020-2026on March 16, 2020 at 4:09 am
Induced Pluripotent Stem Cells Market Size To Expand Rapidly at Notable CAGR as the Rising RandD Investment, Increasing Shift Towards Regenerative Medicine are the factors contributing to the Market ...
- Global induced pluripotent stem cells market is expected to grow with a CAGR of 8.6% over the forecast period from 2019-2025on March 13, 2020 at 5:25 pm
New York, March 13, 2020 -- Reportlinker.com announces the release of the report "Induced Pluripotent Stem Cells Market: Global Industry Analysis, Trends, Market Size, and.
- Stem cells to help the hearton March 12, 2020 at 12:23 pm
2 Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA. See allHide authors and affiliations Shinya Yamanaka's 2006 discovery of induced pluripotent stem cells (iPSCs) ...
- Induced Pluripotent Stem Cells Show Success in Treating Hemophilia A in Miceon March 12, 2020 at 8:30 am
In a new study released today in STEM CELLS Translational Medicine (SCTM), researchers at the University of California, Davis and the Chinese Academy of Science demonstrate how induced pluripotent ...
- Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantationon March 12, 2020 at 3:11 am
Avoiding immune rejection after allogeneic induced pluripotent stem cell-derived cardiomyocyte (iPSC-CM) transplantation is a concern. However, mesenchymal stem cells (MSCs) can suppress immune ...
- Generation of human hepatocytes from extended pluripotent stem cellson March 9, 2020 at 10:23 am
In summary, we established a differentiation protocol to efficiently generate functional hepatocytes from EPS cells, demonstrating the feasibility of applying EPS cells in directed differentiation.
- High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cellson March 4, 2020 at 4:00 pm
To this end, Sharma and colleagues derived heart cells from human induced pluripotent stem cells and then examined how a battery of anticancer tyrosine kinase inhibitors altered their physiology. By ...
via Bing News